Swiss National Bank Castle Biosciences Inc Transaction History

Swiss National Bank

$140 Billion
Q1 2024

A detailed history of Swiss National Bank transactions in Castle Biosciences Inc stock. As of the latest transaction made, Swiss National Bank holds 50,200 shares of CSTL stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,200

Previous 50,200 -0.0%

Holding current value

$1.07 Million

Previous $1.08 Million 2.59%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$12.19 - $22.43 $60,950 - $112,150	-5,000 Reduced 9.06%	50,200 $1.08 Million
Q2 2023 Aug 09, 2023	BUY	$11.66 - $26.0 $79,288 - $176,800	6,800 Added 14.05%	55,200 $757,000
Q1 2023 May 10, 2023	SELL	$19.47 - $28.49 $107,085 - $156,695	-5,500 Reduced 10.2%	48,400 $1.1 Million
Q4 2022 Feb 08, 2023	BUY	$18.08 - $30.0 $18,080 - $30,000	1,000 Added 1.89%	53,900 $1.27 Million
Q3 2022 Nov 09, 2022	BUY	$22.51 - $34.32 $47,271 - $72,072	2,100 Added 4.13%	52,900 $1.38 Million

Q2 2022 Aug 09, 2022	BUY	$16.0 - $45.99 $46,400 - $133,371	2,900 Added 6.05%	50,800 $1.12 Million
Q1 2022 May 09, 2022	BUY	$33.17 - $46.98 $119,412 - $169,128	3,600 Added 8.13%	47,900 $2.15 Million
Q3 2021 Nov 08, 2021	BUY	$60.13 - $77.6 $36,078 - $46,560	600 Added 1.37%	44,300 $2.95 Million
Q2 2021 Aug 06, 2021	BUY	$50.07 - $76.78 $115,161 - $176,594	2,300 Added 5.56%	43,700 $3.21 Million
Q1 2021 May 07, 2021	BUY	$58.92 - $97.33 $29,460 - $48,665	500 Added 1.22%	41,400 $2.83 Million
Q4 2020 Feb 05, 2021	BUY	$43.6 - $73.05 $645,280 - $1.08 Million	14,800 Added 56.7%	40,900 $2.75 Million
Q3 2020 Nov 09, 2020	BUY	$38.47 - $52.03 $19,235 - $26,015	500 Added 1.95%	26,100 $1.34 Million
Q2 2020 Aug 05, 2020	BUY	$27.28 - $43.01 $698,368 - $1.1 Million	25,600 New	25,600 $965,000

Others Institutions Holding CSTL

# of Institutions

162

Shares Held

25.3M

Call Options Held

82.2K

Put Options Held

150K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Castle Biosciences Inc Transaction History